Olympus 2004 Annual Report Download - page 20

Download and view the complete annual report

Please find page 20 of the 2004 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 58

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58

life science
1 8 O LYMPUS 2 0 0 4
DP7 0
M ICRO SCO PE
DIG ITAL CAM ERA
The DP70 features high
reso lutions at 1 2.5
meg apixels, fast image
capture at about three
seconds, a nd high sen-
sitivity that is co mpa -
ra ble to ISO 1 60 0.
REVIEW O F O PERATIO N S
>The Life Science Group was established as a new business gro up
resulting fro m the restructuring o f the Medical Systems G roup in
April 2 0 0 3 . Its main pro ducts are biolo gical microscopes, which
have been with O lympus since its inception; analytical services
for geno mic info rmatio n, which emplo y o ptical technologies
develo ped in micro sco pes; and, in-vitro diagno stic systems such
as clinical chemistry analyz ers, which were an o ffspring o f
involvement in the medical field. Thro ugh substantial technologi-
cal inno vation, O lympus bo asts an approximate 30% share o f the
wo rld market fo r bio lo g ical microscopes. O lympus is the so le
manufacturer o f bo th in-vitro diag nostic equipment and reagents.
O ur diagno stic systems are highly regarded by custo mers, and
co ntinue to grow sharply. W e expect analytical services for
genomic informatio n, a key technolo gy co ntributing to the devel-
o pment of genome medicine, to g ro w into our core business.
In fiscal 2 0 0 4 , sales increased 7 .2 % to ¥71,739 millio n
(US$ 6 5 2 millio n). O wing to ro bust sales g ro wth and efforts to
reduce co sts, o perating income rose 16.1% to ¥3 ,8 2 3 million
(US$ 3 5 millio n). Do mestic sales grew 2 .3 % to ¥19,5 0 2 millio n
(US$ 1 7 7 millio n), and overseas sales advanced 9.1% to
¥5 2 ,2 3 7 million (US$ 4 7 5 million).
The Life Science Group
Bio lo gical micro sco pes
Diagnostic systems
Analytical services for geno mic informatio n
AU2700
AUTO M ATED
CHEM ISTRY AN ALYZER
The AU2 7 00 integ rates
a la rger system's high
thro ughput power with
the flexible emergency
testing capability and
easy operatio ns of a
smaller system.
オリンパス AR04 04.8.4 14:06 ページ 18